WW International Inc banner

WW International Inc
NASDAQ:WW

Watchlist Manager
WW International Inc Logo
WW International Inc
NASDAQ:WW
Watchlist
Price: 17.41 USD -3.06% Market Closed
Market Cap: $173.9m

WW International Inc
Investor Relations

WW International, Inc. engages in the provision of weight management services. The company is headquartered in New York City, New York and currently employs 7,700 full-time employees. The company went IPO on 2001-11-15. The firm offers digital subscription products based on the WW approach to wellness and weight management. Its products provide interactive and personalized resources that allow users to follow its weight management program via its application and Web-based products. The company operates through four geographical segments: North America, Continental Europe (CE), United Kingdom, and Other. The firm's digital business refers to providing subscriptions to its digital product offerings, including Digital 360, and Personal Coaching + Digital. Its Workshops + Digital business provides unlimited access to its workshops combined with its digital subscription product offerings to commitment plan subscribers. The company also includes the provision of access to workshops for members who do not subscribe to commitment plans, including its pay-as-you-go members. Its digital offerings are also provided through workshops, and various events and experiences.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Mar 16, 2026
AI Summary
Q4 2025

Debt reset: The company eliminated over $1.1 billion of debt and reduced legacy debt by more than 70%, freeing capital for investment.

Revenue & profit (Q4): Q4 revenue was $163 million (down 12% YoY) with adjusted EBITDA of $18 million (11.1% margin) and adjusted gross margin of 74.4%.

Clinical momentum: End-of-period clinical subscribers were 130,000 in Q4 and the company expects about 200,000 at the end of Q1 (roughly 100% YoY growth when adjusted for last year’s compounded semaglutide).

Behavioral pressure: End-of-period behavioral subscribers were 2.6 million in Q4; the company expects ~2.45 million at the end of Q1 (about a 26% YoY decline), creating an estimated $50 million subscription revenue headwind for 2026.

Guidance: Fiscal 2026 revenue guidance $620 million–$635 million; adjusted EBITDA guidance $105 million–$115 million.

Product & strategy: Repositioning around integrated weight‑health (behavioral + clinical), launched Med+ clinical offering, GLP-1 Success, new app features and a brand relaunch; marketing front‑loaded to Q1.

Cash & balance sheet: Q4 cash $160 million (down from $170 million in Q3); term loan $465 million at SOFR + 680 bps, maturity June 24, 2030.

Key Financials
End-of-period clinical subscribers
130,000
End-of-period behavioral subscribers
2.6 million
ARPU (monthly subscription revenue per average subscriber)
$18.73
Total revenue (Q4)
$163 million
Clinical revenue growth (Q4)
up 32%
Behavioral revenue change (Q4)
down 17%
Adjusted gross margin (Q4)
74.4%
Marketing expense (Q4)
40% of revenue
Adjusted EBITDA (Q4)
$18 million
Adjusted EBITDA margin (Q4)
11.1%
Cash and cash equivalents (Q4)
$160 million
Term loan
$465 million (SOFR + 680 bps, maturity June 24, 2030)
Debt eliminated
over $1.1 billion
Compounded semaglutide revenue (2025)
$20 million
Opening subscription revenue headwind for 2026
$50 million
Q4 capital expenditures
$7 million
Quarterly interest on term loan (Q4)
$13 million
Full-year 2026 revenue guidance
$620 million to $635 million
Net cash taxes (2025)
$10 million
Core plus as share of behavioral base
around 20%
Member migration (2025)
about 30% of clinical sign-ups transitioned directly from behavioral
Other Earnings Calls

Management

Ms. Tara M. Comonte
Interim CEO & Director
No Bio Available
Ms. Heather Stark C.P.A.
Chief Financial Officer
No Bio Available
Ms. Nicole Haag
Corporate Controller & Principal Accounting Officer
No Bio Available
Mr. Gary D. Foster Ph.D.
Chief Scientific Officer
No Bio Available
Ms. Jacqueline Cooke
General Counsel & Secretary
No Bio Available
Ms. Tiffany Stevenson
Chief People Officer
No Bio Available
Ms. Debra Benovitz
Chief Insights Officer
No Bio Available
Mr. David Cohen
Chief Data Officer
No Bio Available
Mr. Tony Yen
Head of Taiwan
No Bio Available
Ms. Amy Meister D.O.
Chief Medical Officer
No Bio Available

Contacts

Address
NEW YORK
New York City
675 Avenue of the Americas Fl 6
Contacts
+12125892700.0
corporate.ww.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett